340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

HRSA Asks Drugmakers to Verify Their Info in 340B Database

Makes request in connection with new price verification system 

April 28, 2015—The Health Resources and Services Administration has asked drugmakers to verify by May 15 that their information in the 340B program database is complete and up to date.   … [Read more...]

HRSA Submits 340B Information Collection Request to White House

Next step in road to creating ceiling price website 

April 22, 2015 --The Health Resources and Services Administration has submitted an information collection request to the Office of Management and Budget for its review and approval. … [Read more...]

PhRMA Calls Again for Vacating 340B Orphan Drug Rule

Drugmakers request a hearing before judge 

April 16, 2015—The Department of Health and Human Services' 340B orphan drug exclusion interpretive rule violates the 340B statute's plain language and forces drugmakers either to obey "or face an enforcement action where HHS will be the government lawyer, the judge, and the jury," drugmakers say in a new court filing. … [Read more...]

OIG to Investigate Rising Generic Drug Prices

Will determine effect of extending Medicaid rebate inflation penalty to generics 

April 15, 2015—The Department of Health and Human Services Office of Inspector General has told two members of Congress that it plans to determine the amount of additional rebates Medicaid would have received if generic drugs were subject to the same penalty as brand-name drugs when their prices rise faster than the rate of inflation. … [Read more...]

U.S. Drug Spending Soared 13% Last Year to $374 Billion

Study cites expensive new specialty meds as a primary driver 

April 14, 2015—U.S. drug spending increased by 13 percent in 2014 to just under $374 billion – the biggest year-to-year spike since 2001, according to a new report. … [Read more...]

Experts Decry “Unsustainable” Drug Prices

Consensus emerges on need for drug payments to reflect value 

April 9, 2015—The coming "tsunami" of high-priced specialty drugs for cancer and other chronic conditions threatens to undermine the U.S. healthcare system's financial integrity, a panel representing physicians, patients, and payers warned at a Capitol Hill briefing today organized by the Campaign for Sustainable Rx Pricing.   … [Read more...]

340B Rule on Civil Fines for Drugmakers Moves Closer to Release

HRSA sends proposed regulation to White House for review 

April 8, 2015—The Health Resources and Services Administration took a step this morning toward launching a long-delayed system of civil fines for drugmakers that deliberately overcharge for 340B drugs, plus guidance on the calculation of 340B ceiling prices. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health